Abu dhabi: PureHealth Holding, the largest healthcare group in the Middle East, announced its financial results for the three-month period ended 31st March 2026, supported by strong underlying demand and geographic diversification.
According to Emirates News Agency, the Group's revenue increased 10 percent year-on-year to AED7.3 billion, driven by solid growth in PureHealth's international Care (healthcare) portfolio and the Cover (insurance) vertical. PureHealth's EBITDA rose 5 percent year-on-year to AED1.2 billion, supported by the strength of its operating model and continued global expansion.
Net profit reached AED415 million in Q1 2026, reflecting the impact of regulatory developments under the Unified Purchasing Programme (UPP) during the period. Kamal Al Maazmi, Chairman of PureHealth, highlighted the robust growth across the Group, attributing it to sustained demand and disciplined execution. He emphasized the scale and resilience of their integrated Care and Cover model, which offers stability and long-term growth opportunities.
Shaista Asif, Group Chief Executive Officer of PureHealth, noted the resilience across core markets and the growing momentum of their international portfolio. Circle Health and Hellenic Healthcare Group significantly contributed to scaling the international revenue base and reinforcing the strategic rationale for global expansion.
In the UAE, PureHealth continued to expand capacity, deepen clinical complexity, and grow its insurance platform, reflecting the sustained strength of its home market. The Group remains focused on advancing its strategy, reinforcing its position as a leading global healthcare platform, and continuing to build on the strength of its integrated platform.
Looking ahead, PureHealth is well-positioned to deliver sustainable growth, supported by the continued expansion and integration of its international platform, disciplined growth in the Cover vertical, steady demand across its core UAE operations, and ongoing investment in technology and digital capabilities. The Group expects its high-margin international portfolio to play a key role in driving revenue growth and diversification over the medium term, as recently acquired assets continue to scale and deliver synergies.
PureHealth will continue to invest in capacity expansion, service complexity, and high-acuity care across its network, while advancing digital and AI-enabled initiatives to enhance operational efficiency and patient experience.